Diastolic dysfunction in pulmonary artery hypertension: Creatine kinase and the potential therapeutic benefit of beta‐blockers

Fowler, ED, Drinkhill, MJ orcid.org/0000-0002-9007-1130, Stones, R et al. (1 more author) (2018) Diastolic dysfunction in pulmonary artery hypertension: Creatine kinase and the potential therapeutic benefit of beta‐blockers. Clinical and Experimental Pharmacology and Physiology, 45 (4). pp. 384-389. ISSN 0305-1870

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2017, The Authors. Clinical and Experimental Pharmacology and Physiology Published by John Wiley & Sons Australia, Ltd. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
Keywords: beta‐blockers; creatine kinase; diastolic dysfunction; heart failure; pulmonary artery hypertension
Dates:
  • Published: April 2018
  • Accepted: 16 November 2017
  • Published (online): 28 November 2017
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Biological Sciences (Leeds) > School of Biomedical Sciences (Leeds)
Funding Information:
FunderGrant number
British Heart FoundationPG/13/3/29924
Depositing User: Symplectic Publications
Date Deposited: 29 Nov 2017 11:32
Last Modified: 10 May 2018 18:42
Status: Published
Publisher: Wiley
Identification Number: https://doi.org/10.1111/1440-1681.12898

Share / Export

Statistics